Stevanato Group S.p.A. STVN
15.93 USD +0.57 (+3.71%)
Regular-session close
15.93 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
15.06 Day range 15.96
12.05 52-week range 24.01
- YTD
- -20.83%
- 1 year
- -25.35%
News
gurufocus.com Stevanato Group to Participate in Upcoming Investor Conferences [url="]Stevanato Group S.p.A.[/url] (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical,
businesswire.com Stevanato Group to Participate in Upcoming Investor Conferences PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical,…
gurufocus.com STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law [url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
businesswire.com STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $STVN--STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law.benzinga.com UBS Maintains Neutral on Stevanato Group, Lowers Price Target to $16 UBS analyst Doug Schenkel maintains Stevanato Group (NYSE:STVN) with a Neutral and lowers the price target from $23 to $16.
globenewswire.com STVN INVESTOR ALERT: Investigation of Stevanato Group S.p.A. Announced by Holzer & Holzer, LLC ATLANTA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Stevanato Group S.p.A. (“Stevanato” or the “Company”) (NYSE: STVN) complied with federal securities laws. On…benzinga.com Citigroup Maintains Buy on Stevanato Group, Lowers Price Target to $20 Citigroup analyst Albert Hu maintains Stevanato Group (NYSE:STVN) with a Buy and lowers the price target from $26 to $20.
businesswire.com Lost Money on Stevanato Group S.p.A. Shares? The Law Offices of Frank R. LOS ANGELES--(BUSINESS WIRE)--Stevanato Group S.p.A. ("Stevanato" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced…
businesswire.com Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price Drop LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP…
businesswire.com Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G. BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G.…
globenewswire.com Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C. Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Stevanato Group (STVN) investors following the Company's stock price decline
marketbeat.com Stevanato Group Q3 Earnings Call Highlights Stevanato Group NYSE: STVN reported third-quarter 2026 revenue growth of 8% to €326.1 million, supported by continued expansion in its biopharmaceutical and diagnostic solutions business despite…
prnewswire.com Stevanato Group S.p.A. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Stevanato Group S.p.A. STVN shares fell on November 3, 2026, as the market reacted to a lower GLP-1 revenue outlook in Stevanato Group's pre-market third-quarter results, the issue previews had flagged as the quarter's key…
seekingalpha.com Stevanato Group S.p.A. (STVN) Q3 2026 Earnings Call Transcript Stevanato Group S.p.A. ( STVN ) Q3 2026 Earnings Call November 3, 2026 8:30 AM EST Company Participants Lisa Miles - Chief Communications & Investor Relations Officer Franco Stevanato - CEO &…
benzinga.com Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings U.S. stocks were mixed as Nasdaq gained 1%; Pfizer beat Q3 estimates and raised 2026 guidance, while oil, gold and European shares fell.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million. Pasithea Therapeutics (NASDAQ:KTTA) shares increased…
benzinga.com Stevanato Group Q3 2026 Earnings Call Transcript Stevanato Group (NYSE:STVN) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time…
zacks.com Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue Estimates Stevanato Group (STVN) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.16 per share a year ago.benzinga.com Stevanato Group continues to expect revenue in the range of €1.260 billion to €1.280 billion, adjusted EBITDA of €335.0 million to €345.2 million, and adjusted diluted EPS of €0.60 to €0.62. Stevanato Group (NYSE:STVN) continues to expect revenue in the range of €1.260 billion to €1.280 billion, adjusted EBITDA of €335.0 million to €345.2 million, and adjusted diluted EPS of €0.60 to…
benzinga.com Stevanato Gr Q3 Adj. EPS $0.18 Beats $0.17 Estimate, Sales $375.303M Beat $363.840M Estimate Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.17 by 5.88 percent. This is a 12.5 percent increase over earnings of $0.16 per…
businesswire.com Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026 PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical,…
seekingalpha.com Conestoga Small Cap Composite Q3 2026 Portfolio Activity The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return for the Russell 2000 Growth Index. Small Cap Composite top 5 leaders include Repligen, Merit…
businesswire.com Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) (the “Company”), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the…
seekingalpha.com Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital,…
businesswire.com Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026 PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical,…
seekingalpha.com Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
businesswire.com Stevanato Group to Participate in Two Upcoming Investor Conferences PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical,…
